Neurology Research Department, Barrow Neurological Institute, NRC 438, Phoenix, AZ 85013, USA.
BMC Neurosci. 2010 Feb 17;11:19. doi: 10.1186/1471-2202-11-19.
Rett syndrome (RTT), a common cause of mental retardation in girls, is associated with mutations in the MECP2 gene. Most human cases of MECP2 mutation in girls result in classical or variant forms of RTT. When these same mutations occur in males, they often present as severe neonatal encephalopathy. However, some MECP2 mutations can also lead to diseases characterized as mental retardation syndromes, particularly in boys. One of these mutations, A140V, is a common, recurring missense mutation accounting for about 0.6% of all MeCP2 mutations and ranking 21st by frequency. It has been described in familial X-linked mental retardation (XLMR), PPM- X syndrome (Parkinsonism, Pyramidal signs, Macroorchidism, X-linked mental retardation) and in other neuropsychiatric syndromes. Interestingly, this mutation has been reported to preserve the methyl-CpG binding function of the MeCP2 protein while compromising its ability to bind to the mental retardation associated protein ATRX.
We report the construction and initial characterization of a mouse model expressing the A140V MeCP2 mutation. These initial descriptive studies in male hemizygous mice have revealed brain abnormalities seen in both RTT and mental retardation. The abnormalities found include increases in cell packing density in the brain and a significant reduction in the complexity of neuronal dendritic branching. In contrast to some MeCP2 mutation mouse models, the A140V mouse has an apparently normal lifespan and normal weight gain patterns with no obvious seizures, tremors, breathing difficulties or kyphosis.
We have identified various neurological abnormalities in this mouse model of Rett syndrome/X-linked mental retardation which may help to elucidate the manner in which MECP2 mutations cause neuronal changes resulting in mental retardation without the confounding effects of seizures, chronic hypoventilation, or other Rett syndrome associated symptoms.
雷特综合征(RTT)是一种常见的女性智力障碍病因,与 MECP2 基因突变相关。大多数女性 MECP2 基因突变病例会导致经典或变异型 RTT。而当相同的突变发生在男性时,通常会表现为严重的新生儿脑病。然而,一些 MECP2 突变也可导致以智力障碍为特征的疾病,尤其是在男性中。其中一种突变为 A140V,这是一种常见的、反复出现的错义突变,约占所有 MeCP2 突变的 0.6%,按频率排名第 21 位。该突变已在家族性 X 连锁智力障碍(XLMR)、PPM-X 综合征(帕金森病、锥体束征、巨睾症、X 连锁智力障碍)和其他神经精神综合征中有所描述。有趣的是,该突变被报道在保留 MeCP2 蛋白甲基-CpG 结合功能的同时,削弱了其与智力障碍相关蛋白 ATRX 的结合能力。
我们报告了一种表达 A140V MeCP2 突变的小鼠模型的构建和初步特征。这些对雄性半合子小鼠的初步描述性研究揭示了 RTT 和智力障碍中都存在的脑异常。发现的异常包括脑内细胞密度增加和神经元树突分支复杂性显著降低。与一些 MeCP2 突变小鼠模型不同,A140V 小鼠具有明显正常的寿命和正常的体重增加模式,没有明显的癫痫发作、震颤、呼吸困难或脊柱后凸。
我们在该 RTT/X 连锁智力障碍的小鼠模型中发现了各种神经异常,这可能有助于阐明 MECP2 突变导致神经元变化从而导致智力障碍的方式,而没有癫痫发作、慢性通气不足或其他 RTT 相关症状的混杂影响。